22 Jul, 2026
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits or could be harmed? She writes the weekly AI Prognosis newsletter. Follow her on Threads,…
Art and science are often seen as opposites. One is seen as emotional, instinctive and expressive, while the other is logical, measurable and precise. Yet throughout history, the two have…
For decades, getting a diagnosis of endometriosis has often meant years of debilitating symptoms, repeated visits to the GP, tests that came back “normal” and, in many cases, laparoscopic surgery…
Get your daily dose of health and medicine every weekday with STAT’s free Morning Rounds newsletter. Register here. Good morning. I dedicate the first article of today’s newsletter to a…
Sustainability has become one of the defining debates within the creative industries, and rightly so. In art, architecture and design, there is a welcome shift towards the use of reclaimed…

Gilead should provide drug prevention medication in low -income countries

After months of anticipation, Gilead offered an agreement to provide its revolutionary drug on HIV prevention to up to 2 million people in low and intermediate income countries. As part of the New Deal, the Global Fund to combat AIDS, tuberculosis and malaria will be responsible for the purchase and provision of drug doses, known […]

5 mins read

Intratibal insemination with woman | 3 experts react

Explore fertility processing options? You have probably encountered IUI (intrauterine insemination) and IVF (in vitro fertilization), as well as a whole series of drugs. But what happens if there was something between the two? A more recent and less invasive option which is approved by regulatory organizations worldwide, accessible without needing a type of formal […]

6 mins read

Apogee Therapeutics reports the first data on the drug in long -term eczema

Adam Feuerstein is a main writer and biotechnology columnist, reporting on the crossroads of drug development, business, Wall Street and biotechnology. He is also co-host of the weekly biotech podcast The Readout Loud and author of the Biotech dashboard of the Adam newsletter. You can reach Adam on the signal to stataf.54. Apogee Therapeutics said […]

1 min read

Postnatal depletion: two children – and 7 years later – I only take a handful – here are my non -negotiable

My personal depletion chronology With hindsight, I can identify the signs. I felt the worst not In the newborn mist, but years later. It struck when my youngest was about three years old. It is when my rules have become debilitating. My skin broke out. Anxiety has slipped. I was eating well and running (read, […]

3 mins read

Medicaid supporters have misunderstood this important study

There have been a lot of discussions and debates on the Midicaid eligibility cuts that Congress has just passed and, in particular, what they can mean for the current beneficiaries of Medicaid. A key evidence in this debate was the result of Oregon Health Insurance Experiment (Ohie), a randomized trial, which I helped to direct, […]

6 mins read

The year is half over. Here is where the biotechnology industry is located

Adam Feuerstein is a main writer and biotechnology columnist, reporting on the crossroads of drug development, business, Wall Street and biotechnology. He is also co-host of the weekly biotech podcast The Readout Loud and author of the Biotech dashboard of the Adam newsletter. You can reach Adam on the signal to stataf.54. This is the […]

1 min read

Psychedelic therapy is promising in the depression study resistant to treatment

Experimental psychedelic therapy of the British company Beckley Psytech has considerably reduced the symptoms of depression resistant to treatment in a mid-term test, according to recently published data, which increases the expectations of a class of drugs which are directed towards potential approval by American regulators. Companies like Beckley, Atai Life Sciences and Compass Pathways […]

1 min read